187 related articles for article (PubMed ID: 34694277)
1. A Comparison of Single-Dose Versus Multidose Metronidazole by Select Clinical Factors for the Treatment of Trichomonas vaginalis in Women.
Muzny CA; Mena LA; Lillis RA; Schmidt N; Martin DH; Kissinger P
Sex Transm Dis; 2022 Mar; 49(3):231-236. PubMed ID: 34694277
[TBL] [Abstract][Full Text] [Related]
2. The influence of bacterial vaginosis on the response to Trichomonas vaginalis treatment among HIV-infected women.
Gatski M; Martin DH; Levison J; Mena L; Clark RA; Murphy M; Henderson H; Schmidt N; Kissinger P
Sex Transm Infect; 2011 Apr; 87(3):205-8. PubMed ID: 21278401
[TBL] [Abstract][Full Text] [Related]
3. A randomized treatment trial: single versus 7-day dose of metronidazole for the treatment of Trichomonas vaginalis among HIV-infected women.
Kissinger P; Mena L; Levison J; Clark RA; Gatski M; Henderson H; Schmidt N; Rosenthal SL; Myers L; Martin DH
J Acquir Immune Defic Syndr; 2010 Dec; 55(5):565-71. PubMed ID: 21423852
[TBL] [Abstract][Full Text] [Related]
4. The Association Between Human Immunodeficiency Virus and Bacterial Vaginosis and Metronidazole Treatment Failure for Trichomonas vaginalis.
Frechtling D; Chopra S; Ratnayake A; Kissinger PJ
Sex Transm Dis; 2024 Jan; 51(1):61-64. PubMed ID: 37921835
[TBL] [Abstract][Full Text] [Related]
5. The influence of ART on the treatment of Trichomonas vaginalis among HIV-infected women.
Adamski A; Clark RA; Mena L; Henderson H; Levison J; Schmidt N; Gebrekristos HT; Martin DH; Kissinger P
Clin Infect Dis; 2014 Sep; 59(6):883-7. PubMed ID: 24917661
[TBL] [Abstract][Full Text] [Related]
6. Unexpected High Rates of Persistent Trichomonas vaginalis Infection in a Retrospective Cohort of Treated Pregnant Women.
Lazenby GB; Thompson L; Powell AM; Soper DE
Sex Transm Dis; 2019 Jan; 46(1):2-8. PubMed ID: 30067546
[TBL] [Abstract][Full Text] [Related]
7. Single-dose versus 7-day-dose metronidazole for the treatment of trichomoniasis in women: an open-label, randomised controlled trial.
Kissinger P; Muzny CA; Mena LA; Lillis RA; Schwebke JR; Beauchamps L; Taylor SN; Schmidt N; Myers L; Augostini P; Secor WE; Bradic M; Carlton JM; Martin DH
Lancet Infect Dis; 2018 Nov; 18(11):1251-1259. PubMed ID: 30297322
[TBL] [Abstract][Full Text] [Related]
8. Optimal Timing for Trichomonas vaginalis Test of Cure Using Nucleic Acid Amplification Testing.
Craig-Kuhn MC; Granade C; Muzny CA; Van Der Pol B; Lillis R; Taylor SN; Schmidt N; Martin DH; Kissinger P
Sex Transm Dis; 2019 May; 46(5):312-316. PubMed ID: 30601374
[TBL] [Abstract][Full Text] [Related]
9. Vulvovaginitis: screening for and management of trichomoniasis, vulvovaginal candidiasis, and bacterial vaginosis.
van Schalkwyk J; Yudin MH;
J Obstet Gynaecol Can; 2015 Mar; 37(3):266-274. PubMed ID: 26001874
[TBL] [Abstract][Full Text] [Related]
10. Impact of oral metronidazole treatment on the vaginal microbiota and correlates of treatment failure.
Verwijs MC; Agaba SK; Darby AC; van de Wijgert JHHM
Am J Obstet Gynecol; 2020 Feb; 222(2):157.e1-157.e13. PubMed ID: 31404542
[TBL] [Abstract][Full Text] [Related]
11. Diagnosis and Management of Trichomonas vaginalis: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.
Kissinger PJ; Gaydos CA; Seña AC; Scott McClelland R; Soper D; Secor WE; Legendre D; Workowski KA; Muzny CA
Clin Infect Dis; 2022 Apr; 74(Suppl_2):S152-S161. PubMed ID: 35416973
[TBL] [Abstract][Full Text] [Related]
12. Sexual intercourse association with asymptomatic bacterial vaginosis and Trichomonas vaginalis treatment in relationship to preterm birth.
Berghella V; Klebanoff M; McPherson C; Carey JC; Hauth JC; Ernest JM; Heine RP; Wapner RJ; Trout W; Moawad A; Leveno KJ; Miodovnik M; Sibai BM; Van Dorsten JP; Dombrowski MP; O'Sullivan MJ; Varner M; Langer O;
Am J Obstet Gynecol; 2002 Nov; 187(5):1277-82. PubMed ID: 12439520
[TBL] [Abstract][Full Text] [Related]
13. Trichomonas vaginalis Virus Among Women With Trichomoniasis and Associations With Demographics, Clinical Outcomes, and Metronidazole Resistance.
Graves KJ; Ghosh AP; Schmidt N; Augostini P; Secor WE; Schwebke JR; Martin DH; Kissinger PJ; Muzny CA
Clin Infect Dis; 2019 Nov; 69(12):2170-2176. PubMed ID: 30768180
[TBL] [Abstract][Full Text] [Related]
14. Probiotics in addition to metronidazole for treatment Trichomonas vaginalis in the presence of BV: a randomized, placebo-controlled, double-blind study.
Sgibnev A; Kremleva E
Eur J Clin Microbiol Infect Dis; 2020 Feb; 39(2):345-351. PubMed ID: 31705339
[TBL] [Abstract][Full Text] [Related]
15. Single-Dose Compared With Multidose Metronidazole for the Treatment of Trichomoniasis in Women: A Meta-Analysis.
Howe K; Kissinger PJ
Sex Transm Dis; 2017 Jan; 44(1):29-34. PubMed ID: 27898571
[TBL] [Abstract][Full Text] [Related]
16. A prospective cohort study comparing the effect of single-dose 2 g metronidazole on Trichomonas vaginalis infection in HIV-seropositive versus HIV-seronegative women.
Balkus JE; Richardson BA; Mochache V; Chohan V; Chan JD; Masese L; Shafi J; Marrazzo J; Farquhar C; McClelland RS
Sex Transm Dis; 2013 Jun; 40(6):499-505. PubMed ID: 23677023
[TBL] [Abstract][Full Text] [Related]
17. Bacterial vaginosis and risk for Trichomonas vaginalis infection: a longitudinal analysis.
Rathod SD; Krupp K; Klausner JD; Arun A; Reingold AL; Madhivanan P
Sex Transm Dis; 2011 Sep; 38(9):882-6. PubMed ID: 21844747
[TBL] [Abstract][Full Text] [Related]
18. Clinical Validation of the Aptima Bacterial Vaginosis and Aptima
Schwebke JR; Taylor SN; Ackerman R; Schlaberg R; Quigley NB; Gaydos CA; Chavoustie SE; Nyirjesy P; Remillard CV; Estes P; McKinney B; Getman DK; Clark C
J Clin Microbiol; 2020 Jan; 58(2):. PubMed ID: 31748322
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of nitazoxanide against some metronidazole-resistant and susceptible Trichomonas vaginalis isolates.
Abdel-Magied AA; Hammouda MM; Mosbah A; El-Henawy AA
J Infect Chemother; 2017 Apr; 23(4):230-233. PubMed ID: 28131737
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Male Sexual Partners of Women With Bacterial Vaginosis: A Randomized, Double-Blind, Placebo-Controlled Trial.
Schwebke JR; Lensing SY; Lee J; Muzny CA; Pontius A; Woznicki N; Aguin T; Sobel JD
Clin Infect Dis; 2021 Aug; 73(3):e672-e679. PubMed ID: 33383580
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
